At $850,000, price for new childhood blindness gene therapy four times too high, analysis says
Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.
Watch 3:34
Why I used to love making jokes about Helen Keller
Growing up, Georgina Kleege hated Helen Keller; she saw the famous author and activist as a reproach to her own experience as a young blind woman. But she found a new way to relate to Keller later on, writing her…
Watch 5:58
Smart cane may help visually impaired navigate more terrain
A high-tech upgrade to the traditional white cane may help blind and visually impaired people be more confident about navigating the world independently. The NewsHour's April Brown reports from France.
Two Decades On, India Eye Clinic Maintains Innovative Mission
In this Reporter's Notebook, Fred de Sam Lazaro visits the Aravind Eye Care System, 20 years after he first reported on the hospital in 1989.
Additional Support Provided By:
